AstraZeneca PLC Holdings Report: Capital Group Boosts Voting Rights to 5.01%

Here are the key details extracted from the financial report (Form 6-K) regarding holdings in AstraZeneca PLC:

General Information

Form Type: 6-K
Issuer: AstraZeneca PLC
Commission File Number: 001-11960
Document Date: 26 August 2025
Reporting Period: August 2025

Holdings Notification

ISIN: GB0009895292
Type of Issuer: UK
Reason for Notification: Acquisition or disposal of voting rights

Shareholder Details

Name of Shareholder: The Capital Group Companies, Inc.
City of Registered Office: Los Angeles
Country of Registered Office: USA

Voting Rights Details

Date Threshold Crossed: 22 August 2025
Date Issuer Notified: 25 August 2025
Voting Rights Held:
Total Voting Rights: 77,684,561
Percentage of Voting Rights: 5.009701%
Previous Notification Percentage: 4.997854%

Breakdown of Holdings

Voting Rights Attached to Shares:

Common Stock (ISIN: GB0009895292): 62,998,778 shares (4.062648%)
Depository Receipts (ISIN: US0463531089): 14,685,783 shares (0.947053%)
Total Voting Rights from Shares: 77,684,561 (5.009701%)

Financial Instruments:

Voting Rights through Financial Instruments:
- No voting rights reported from financial instruments.

Additional Information

The Capital Group Companies, Inc. is the parent company of several investment management firms, and the shares reported are held in accounts under discretionary investment management.

Signatory

Signed by: Matthew Bowden, Company Secretary, AstraZeneca PLC

This report indicates a modest increase in the percentage of voting rights held by The Capital Group Companies, Inc. in AstraZeneca PLC, suggesting potential strategic positioning or investment interest in the company.